Liquid biopsy integration creating expansion — circulating tumor DNA (ctDNA) and cell-free DNA (cfDNA) analysis through targeted sequencing enabling noninvasive cancer genomic profiling through blood testing rather than invasive tissue biopsy, establishing liquid biopsy as accessible cancer genomics approach supporting early detection, treatment monitoring, and minimal residual disease...
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek